WFM
CLB icon

Wilmington Funds Management’s Core Laboratories CLB Stock Holding History

Wilmington Funds Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$5.49M Buy
32,850
+9,405
+40% +$1.67M 0.56% 52
2014
Q1 		$4.65M Buy
23,445
+3,000
+15% +$566K 0.51% 65
2013
Q4 		$3.9M Sell
20,445
-3,980
-16% -$741K 0.39% 84
2013
Q3 		$4.13M Sell
24,425
-5,410
-18% -$840K 0.4% 84
2013
Q2 		$4.53M Buy
+29,835
New +$4.23M 0.43% 76

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wilmington Funds Management's CLB Position: Q2 2014 in Review

Wilmington Funds Management increased its Core Laboratories (CLB) stake by 40% in Q2 2014, buying an estimated $1.67M and bringing the position to 32,850 shares worth $5.49M. The position accounts for 0.56% of the portfolio, ranked #52.

Wilmington Funds Management first reported a position in CLB in Q2 2013 and has held it in 5 quarters since. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • Wilmington Funds Management held 32,850 shares of Core Laboratories worth $5.49M as of Q2 2014.
  • Wilmington Funds Management bought 9,405 Core Laboratories shares in Q2 2014, an estimated $1.67M.
  • Core Laboratories made up 0.56% of Wilmington Funds Management's portfolio in Q2 2014, its #52 holding.
  • Wilmington Funds Management first reported a position in Core Laboratories in Q2 2013 and has held it in 5 quarters since.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.